The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Smart Tissue Autonomous Robot (STAR) Market During The Forecast Period?

The smart tissue autonomous robot (star) market has seen substantial growth in recent years. It is projected to expand from $0.3 billion in 2025 to $0.36 billion in 2026, at a compound annual growth rate (CAGR) of 20.3%. The historical increase can be attributed to several factors including the rise of robotic surgery platforms, increased demand for minimally invasive surgery, progress in surgical imaging, investments in hospital robotics, and the need for precision surgery.

The smart tissue autonomous robot (star) market size is anticipated to expand significantly over the coming years. It is projected to reach $0.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.5%. This expansion during the forecast period stems from factors such as expanded research in autonomous surgery, the incorporation of AI into surgical workflows, a heightened demand for sophisticated sensing instruments, an emphasis on consistent surgical outcomes, and investment in next-generation surgical robotics. Prominent trends foreseen for the same period involve autonomous soft tissue suturing systems, AI-powered surgical decision engines, robotics for real-time tissue tracking, force feedback surgical instruments, and image-driven robotic navigation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33322&type=smp

What Core Drivers Are Transforming The Smart Tissue Autonomous Robot (STAR) Market?

The increasing need for minimally invasive surgical techniques is projected to boost the expansion of the smart tissue autonomous robot (STAR) market in the future. These procedures involve operations conducted via tiny cuts or natural orifices utilizing specialized tools, aiming to lessen tissue damage, blood loss, and recovery periods while preserving surgical exactness. A key factor driving this heightened demand for minimally invasive surgeries is improved patient safety. The smart tissue autonomous robot (STAR) facilitates this growing demand for minimally invasive procedures by accurately carrying out intricate soft-tissue manipulations via small incisions, thereby lessening human mistakes, diminishing tissue harm, and enhancing overall surgical precision and patient healing. For example, in June 2024, as reported by the American Society of Plastic Surgeons, a US-based non-profit organization, hyaluronic acid filler minimally invasive procedures reached 5.29 million in 2023, marking an 8% rise compared to 2022. Consequently, the escalating demand for minimally invasive surgical procedures is propelling the growth of the smart tissue autonomous robot (STAR) market. Hospital investments in robotic infrastructure are set to drive the expansion of the smart tissue autonomous robot (STAR) market moving forward. Robotic infrastructure encompasses the collective robotic systems, along with the essential software, hardware, and facilities needed for the effective setup, operation, and upkeep of robotic technologies within a healthcare institution. A primary impetus for these increasing hospital investments in robotic infrastructure is the imperative to enhance surgical exactness. The smart tissue autonomous robot (STAR) assists expanding hospital investments in robotic infrastructure by providing a sophisticated autonomous surgical platform that combines artificial intelligence, imaging, and precise robotics, thus allowing hospitals to elevate their surgical capacities, achieve better clinical results, and optimize the returns on their robotic technology expenditures. For instance, in Nov 2025, Springer Nature, a Germany-based academic and scientific publishing company, documented that surgical robot ownership across trusts increased by 42%, from 36 to 51, with its application extending to 49 trusts for general surgery and doubling for emergency procedures, going from 13 to 26 trusts. Consequently, the growing hospital investments in robotic infrastructure are propelling the growth of the smart tissue autonomous robot (STAR) market.

Which Segment-Based Categories Are Covered In The Smart Tissue Autonomous Robot (STAR) Market?

The smart tissue autonomous robot (star) market covered in this report is segmented –

1) By Component: Hardware; Software

2) By Surgical Technique: Open Surgery; Minimally Invasive Surgery; Endoscopic Surgery

3) By Technology: Artificial Intelligence; Machine Learning; Computer Vision; Robotic Manipulation

4) By Application: Soft Tissue Surgery; Plastic And Reconstructive Surgery; Orthopedic Surgery; Gastrointestinal Surgery; Cardiothoracic Surgery

5) By End-User: Hospitals; Ambulatory Surgical Centers; Research Institutions; Clinics

Subsegments:

1) By Hardware: Sensors; Actuators; Robotic Arms; Control Units; Imaging Modules; Power Systems

2) By Software: Algorithmic Control Software; Machine Learning Platforms; Surgical Planning Software; Real Time Navigation Software; Image Processing Software; Data Analytics Software

Which Organizations Are Operating Within The Smart Tissue Autonomous Robot (STAR) Market?

Major companies operating in the smart tissue autonomous robot (star) market are Johnson & Johnson, Medtronic, ABB Ltd, Siemens Healthineers, Stryker Corporation, Philips, Boston Scientific, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Smith & Nephew plc, KARL STORZ, Globus Medical, Inc., Renishaw plc, CMR Surgical Limited, Osso VR, Caresyntax, Think Surgical, Inc, Activ Surgical, Tuodao Medical, Sina Robotics & Medical Innovators Co

Access The Complete Smart Tissue Autonomous Robot (STAR) Market Report:

https://www.thebusinessresearchcompany.com/report/smart-tissue-autonomous-robot-star-market-report

Which Region Leads The Smart Tissue Autonomous Robot (STAR) Market By Size?

North America was the largest region in the smart tissue autonomous robot (STAR) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart tissue autonomous robot (star) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Smart Tissue Autonomous Robot (STAR) Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model